Mecardis Tablet 80 mg (Telmisartan)

Adult dose

1. Essential Hypertension Telmisartan is to be administered orally as 40 mg once daily with water, and may be taken regardless of meals. Depending on the patient's situation, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. When increasing the dosage, the maximum antihypertensive effect appears 4 to 8 weeks after starting treatment. 2. Reduction of Cardiovascular Disease Risk This medicine

This medicine can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals with hypersensitivity to this drug, pregnant or breastfeeding women, patients with severe liver impairment, individuals with a history of angioedema, and certain kidney and diabetes patients. Elderly patients, patients with hyperkalemia, liver disease, and those with heart and kidney disease should use this medicine cautiously, as there is a risk of significant drops in blood pressure. Various adverse reactions may occur while taking this medicine, and especially if symptoms such as hypotension, hyperkalemia, kidney dysfunction, or angioedema appear, immediate consultation with a healthcare provider is necessary. Patients with decreased kidney function should regularly check their serum potassium and creatinine levels, and patients with decreased blood volume may experience hypotensive symptoms; therefore, their status should be corrected before taking this medicine. The effect may be enhanced or adverse effects may increase when this medicine is taken with other antihypertensive agents, so healthcare providers should be informed about any concurrent medications. Caution is particularly needed when combined with lithium, non-steroidal anti-inflammatory drugs, and potassium-sparing diuretics; monitoring of serum levels may be recommended if necessary. This medicine should not be taken during pregnancy, and breastfeeding women should either avoid taking this medicine or stop breastfeeding. Safety and efficacy have not been established in children under 18 years of age, so it is not recommended for them. Elderly patients should be administered this medicine cautiously to avoid excessive blood pressure lowering, and they should be careful while driving or operating machinery due to the risk of dizziness or fainting. Overdose may cause hypotension, dizziness, acute kidney failure, etc., and immediate medical treatment should be sought. This medicine should be kept out of the reach of children and should remain sealed until just before use.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa, severe skin reactions, difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, liver abnormalities (liver dysfunction, jaundice), sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, vision.

Mild side effects

Upper respiratory tract infections (including pharyngitis, sinusitis), urinary tract infections, cystitis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, hyperkalemia, hypoglycemia, hyponatremia, depression, insomnia, anxiety, fainting, drowsiness, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, cough, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, taste disturbances, increased sweating, itching, rash, erythema,

This medicine may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the effectiveness of the medicine.

Appearance

This medicine is a white or off-white, oval tablet with a biconvex shape.

Package unit

30 tablets (10 tablets/PTP x 3)